The store will not work correctly when cookies are disabled.
2-(4-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296209
PubChem CID: 76316650
Max Phase: Preclinical
Molecular Formula: C20H13ClN4O2S
Molecular Weight: 408.87
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#CC(C#N)=Cc1ccc(OCCSc2nnc(-c3ccc(Cl)cc3)o2)cc1
Standard InChI: InChI=1S/C20H13ClN4O2S/c21-17-5-3-16(4-6-17)19-24-25-20(27-19)28-10-9-26-18-7-1-14(2-8-18)11-15(12-22)13-23/h1-8,11H,9-10H2
Standard InChI Key: TWTBJXYZGZIUTB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.9373 -15.0947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7527 -15.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1596 -14.3914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7523 -13.6853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9337 -13.6881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5305 -14.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9768 -14.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4562 -15.0499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2344 -14.7975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2333 -13.9791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4545 -13.7287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9502 -15.1916 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.6497 -14.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6336 -13.9522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3332 -13.5298 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0488 -13.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0595 -14.7393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7742 -15.1338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4748 -14.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4560 -13.8901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7407 -13.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1909 -15.1050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8899 -14.6816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6060 -15.0753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8727 -13.8646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8588 -13.0519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3188 -15.4690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7133 -14.3956 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
6 28 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 408.87 | Molecular Weight (Monoisotopic): 408.0448 | AlogP: 4.99 | #Rotatable Bonds: 7 |
Polar Surface Area: 95.73 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.48 | CX LogD: 4.48 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.31 | Np Likeness Score: -1.89 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |